NASDAQ
Sinopharm Group Co. Ltd. (SHTDY) has a free cash flow growth of 236.00% as of Friday, May 29, 2026. This represents a 705.48% increase compared to its 12-month average of 29.30%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.